论文部分内容阅读
(一) 三九企业集团(以下简称“三九”)从1985年筹建其前身南方制药厂,经过十六年的努力,已发展成为一个大型的医药企业集团,连续几年销售额、利税、利润三项指标在全国医药行业都雄居第一,但与世界著名药业企业比仍有巨大差距。新世纪伊始,三九总裁赵新先就提出三九要在10年内成为亚洲制药业第一的目标,这意味着要达到30亿美元以上的年销售额。而1999年三九的年销售额也仅有74亿元人
(i) Sanjiu Enterprise Group (hereinafter referred to as “Sanjiu”) established its predecessor, Nanfang Pharmaceutical Factory, in 1985. After 16 years of hard work, it has developed into a large-scale pharmaceutical enterprise group with consecutive sales for several years. The three indicators of profits, taxes and profits rank first in the nation’s pharmaceutical industry, but there is still a huge gap with the world’s leading pharmaceutical companies. At the beginning of the new century, Zhao Xinxian, the president of Sanjiu, proposed that Sanjiu must be the first target of the Asian pharmaceutical industry within 10 years, which means that it must achieve annual sales of over US$3 billion. In 1999, the annual sales amounted to only 7.4 billion yuan.